To help facilitate the implementation of TB screening at the country level, WHO published guidelines on screening for TB in 2013. Since then, there have been important new studies evaluating the impact of screening interventions on both individual-level and community-level outcomes related to TB, as well as new research evaluating innovative tools for screening for TB among important populations at high risk for TB disease.


In view of these new developments and upon demand by countries for more guidance, WHO convened a Guideline Development Group (GDG) in 2020 to examine the evidence and prepare WHO consolidated guidelines on tuberculosis. Module 2: Screening – Systematic screening for tuberculosis disease. As a result of this process a set of 17 new and updated recommendations for the screening of TB disease have been developed. These recommendations identify contacts of TB patients, people living with HIV, people exposed to silica, prisoners and other key populations to be prioritized for TB screening. The new guidance also recommends different tools for screening, namely symptom screening, chest radiography, computer-aided detection software, molecular WHO-approved rapid diagnostic tests, and C-reactive protein. The new recommendations are being released as part of a modular series of WHO guidance on TB and are accompanied by a complementary implementation guide.


You may also like